Figure 4.
Cumulative percentage of patients who achieved ADAMTS13 activity ≥ 20% after the last therapeutic plasma exchange in the triplet regimen (red columns) and the historical cohort (blue columns). ADAMTS13 activity was assessed weekly until normalization or day 56.